Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 173-190 , February 2008

Regulation of fetal growth: Consequences and impact of being born small

  • Primus-E. Mullis, MD (Professor, Doctor, Head of Division of Paediatric Endocrinology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +41 31 632 9552; Fax: +41 31 632 9550.
    • ,
  • Paolo Tonella, MSc (Clinical Research Fellow at the Division of Paediatric Endocrinology)

References 

  1. Tanner JM. Fetus into Man: Physical Growth from Conception to Maturity. 2nd edn. Cambridge, MA: Harvard University Press; 1978;
  2. Arey LB. Developmental Anatomy. 7th edn. Philadelphia: W.B. Saunders; 1966;
  3. de Pablo F, Scott LA, Roth J. Insulin and insulin-like-growth factor I in early development: peptides, receptors and biological events. Endocrine Reviews. 1990;11:558–577
  4. Bryan SM, Hindmarsh PC. Normal and abnormal fetal growth. Hormone Research. 2006;65(Suppl 3):19–27
  5. Bakketeig LS. Current growth standards, definitions, diagnosis and classification of fetal growth retardation. European Journal of Clinical Nutrition. 1998;52(Suppl 1):1–4
  6. Singer DB, Sung CJ, Wigglesworth JS. Fetal growth and maturation. In:  Wigglesworth JS,  Singer DB editor. Textbook of Fetal and Perinatal Pathology. Boston: Blackwell Scientific, Publications; 1996;p. 11–47
  7. Bakketeig LS, Butte N, de Onis M, et al. Report of the IDECG Working Group on definitions, classifications, causes, mechanisms and prevention of IUGR. European Journal of Clinical Nutrition. 1998;52(Suppl 1):94–96
  8. Hindmarsh PC, Geary MP, Rodeck CH, et al. Intrauterine growth and its relationship to size and shape at birth. Pediatric Research. 2002;52:263–268
  9. Gluckman PD, Hanson MA. The consequences of being born small – an adaptive response. Hormone Research. 2006;65(Suppl 3):5–14
  10. Ounsted M, Scott A, Moar VA. Constrained and unconstrained fetal growth: associations with some biological and pathological factors. Annals of Human Biology. 1988;15:119–129
  11. Drake AJ, Walker BR, Seckl JR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005;288:34–38
  12. Drake AJ, Walker BR. The intergenerational effects of fetal programming: non-genomic mechanisms for the inheritance of low birth weight and cardiovascular risk. The Journal of Endocrinology. 2004;180:1–16
  13. Haig D. Genetic conflicts in human pregnancy. The Quarterly Review of Biology. 1993;68:495–532
  14. Haig D. Alteration of generations: genetic conflicts of pregnancy. American Journal of Reproductive Immunology. 1996;35:226–232
  15. Gluckman PD, Hanson MA, Spencer HG, et al. Proceedings Biological Sciences. 2005;272:671–677
  16. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Seminars in Fetal & Neonatal Medicine. 2004;9:419–425
  17. Bauer MK, Harding JE, Bassett NS, et al. Fetal growth and placental function. Molecular and Cellular Endocrinology. 1998;140:115–120
  18. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733–1736
  19. Lillycrop KA, Phillips ES, Jackson AA, et al. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. The Journal of Nutrition. 2005;135:1382–1386
  20. Bloomfield FH, Oliver MH, Giannoulias CD, et al. Brief under-nutrition in late-gestation sheep programs the hypothalamic-pituitary-adrenal axis in adult offspring. Endocrinology. 2003;144:2933–2940
  21. Oliver MH, Bloomfield FH, Harding JE, et al. The maternal, fetal and postnatal somatotrophic axes in intrauterine growth retardation. Biochemical Society Transactions. 1999;27:69–73
  22. Langley-Evans SC, Phillips GJ, Benediktsson R, et al. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta. 1996;17:169–172
  23. Gluckman PD, Harding JE. Fetal growth retardation: underlying endocrine mechanisms and postnatal consequences. Acta Paediatrica. 1997;422:69–72
  24. Butler NR, Goldstein H, Ross EM. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. British Medical Journal. 1972;2:127–130
  25. Geary M, Crowley D, Boylan P. Passive cigarette smoking in pregnancy. Journal of Obstetrics and Gynaecology. 1997;17:264–265
  26. Kalousek DK, Vekemans M. Confined placental mosaicism. Journal of Medical Genetics. 1996;33:529–533
  27. Monk D, Bentley L, Hitchins M, et al. Chromosome 7p disruptions in Silver Russell syndrome: delineating an imprinted candidate gene region. Human Genetics. 2002;111:376–387
  28. Walton A, Hammond J. The maternal effects on growth and confirmation in Shire horse-Shetland pony crosses. Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character. 1938;125:311–335
  29. Hitchins MP, Moore GE. Genomic imprinting in fetal growth and development. Expert Reviews in Molecular Medicine. 2002;2002:1–19
  30. Reik W, Davies K, Dean W, et al. Imprinted genes and the coordination of fetal and postnatal growth in mammals. Novartis Foundation Symposium. 2001;237:19–31
  31. Constancia M, Kelsey G, Reik W. Resourceful imprinting. Nature. 2004;432:53–57
  32. Tycko B, Morison IM. Physiological functions of imprinted genes. Journal of Cellular Physiology. 2002;192:245–258
  33. Fowden AL, Sibley C, Reik W, et al. Imprinted genes, placental development and fetal growth. Hormone Research. 2006;65(Suppl 3):50–58
  34. Moore T. Genetic conflict, genomic imprinting and establishment of the epigenotype in relation to growth. Reproduction. 2001;122:185–193
  35. Gicquel C, Le Bouc Y. Hormonal regulation of fetal growth. Hormone Research. 2006;65(Suppl 3):28–33
  36. Gaston V, Le Bouc Y, Soupre V, et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. European Journal of Human Genetics. 2001;9:409–418
  37. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991;64:849–859
  38. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature. 1990;345:78–80
  39. Wang ZQ, Fung MR, Barlow DP, et al. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature. 1994;372:464–467
  40. Ludwig T, Eggenschwiler J, Fisher P, et al. Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Developmental Biology. 1996;177:517–535
  41. Woods KA, Camacho-Hubner C, Savage MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. The New England Journal of Medicine. 1996;335:1363–1367
  42. Rosenfeld RG. Molecular mechanisms of IGF-I deficiency. Hormone Research. 2006;65(Suppl 1):15–20
  43. Rosenfeld RG. The IGF system: new developments relevant to pediatric practice. Endocrine Development. 2005;9:1–10
  44. Magnus P. Causes of variation in birth weight: a study of offspring of twins. Clinical Genetics. 1984;25:15–24
  45. Magnus P, Berg K, Bjerkedal T, et al. Parental determinants of birth weight. Clinical Genetics. 1984;26:397–405
  46. Magnus P. Further evidence for a significant effect of fetal genes on variation in birth weight. Clinical Genetics. 1984;26:289–296
  47. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF-I gene: clinical relevance for short children born small for gestational age (SGA). The Journal of Clinical Endocrinology and Metabolism. 2002;87:2720
  48. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002;359:1036–1037
  49. Johnston LB, Dahlgren J, Leger J, et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. The Journal of Clinical Endocrinology and Metabolism. 2003;88:4805–4810
  50. Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nature Genetics. 1998;19:268–270
  51. Dunger DB, Ong KK, Huxtable SJ, et al. Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nature Genetics. 1998;19:98–100
  52. Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet. 1999;353:1789–1792
  53. Mullis PE. Genetic control of growth. European Journal of Endocrinology. 2005;152:11–31
  54. Kaplan SL, Grumbach MM, Shepard TH. The ontogenesis of human fetal hormones. I. Growth hormone and insulin. The Journal of Clinical Investigation. 1972;51:3080–3093
  55. Frankenne F, Closset J, Gomez F, et al. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. The Journal of Clinical Endocrinology and Metabolism. 1988;66:1171–1180
  56. de Zegher F, Vanderschueren-Lodeweyckx M, Spitz B, et al. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. The Journal of Clinical Endocrinology and Metabolism. 1990;77:520–522
  57. Hindmarsch P. Hormonal levels in the human fetus between 14 and 22 weeks gestation. Early Human Development. 1987;15:253–258
  58. Lassare C, Hardouin S, Daffos F, et al. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatric Research. 1991;29:219–225
  59. Giudice LC, de Zegher F, Gargosky SE, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. The Journal of Clinical Endocrinology and Metabolism. 1995;80:1548–1555
  60. de Zegher F, Bettendorf M, Kaplan SL, et al. Hormone ontogeny in the ovine fetus and neonatal lamb. XXI. Effect of exogenous insulin-like growth factor-1 on plasma growth hormone, insulin and glucose concentrations. Endocrinology. 1988;123:658–660
  61. de Zegher F, Pernasetti F, Vanhole C, et al. The prenatal role of thyroid hormone evidenced by fetomaternal pit-1 deficiency. The Journal of Clinical Endocrinology and Metabolism. 1995;80:3127–3130
  62. Parkes MJ, Bassett JM. Antagonism by growth hormone of insulin action in fetal sheep. The Journal of Endocrinology. 1985;105:379–382
  63. Stevens D, Alexander G. Lipid deposition after hypophysectomy and growth hormone treatment in the sheep fetus. Journal of Developmental Physiology. 1986;8:139–145
  64. de Zegher F, Francois I, van Helvoirt M, et al. Clinical review 89: Small as fetus and short as child: from endogenous to exogenous growth hormone. The Journal of Clinical Endocrinology and Metabolism. 1997;82:2021–2026
  65. Deiber M, Chatelain P, Naville D, et al. Functional hypersomatotropism in small for gestational age (SGA) newborn infants. The Journal of Clinical Endocrinology and Metabolism. 1989;68:232–234
  66. Bauer MK, Breier BB, Bloomfield FH, et al. Chronic pulsatile infusion of growth hormone to growth-restricted fetal sheep increases circulating fetal insulin-like growth factor-I levels but not fetal growth. Journal of Endocrinology. 2003;177:83–92
  67. Cianfarani S, Geremia C, Scott CD, et al. Growth, IGF system, and cortisol in children with intrauterine growth retardation: is catch-up growth affected by reprogramming of the hypothalamic-pituitary-adrenal axis?. Pediatric Research. 2002;51:94–99
  68. Bloomfield FH, van Zijl PL, Bauer MK, et al. Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues. American Journal of Physiology Endocrinology and Metabolism. 2006;291:E333–E339
  69. Fleenor D, Oden J, Kelly PA, et al. Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology. 2005;146:103–112
  70. Freemark M, Driscoll P, Maaskant R, et al. Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development. The Journal of Clinical Investigation. 1997;99:1107–1117
  71. Freemark M. The roles of growth hormone, prolactin and placental lactogen in human fetal development. In:  Handweger S editors. Molecular and Cellular Pediatric Endocrinology. Totowa NJ: Humana; 1999;p. 57–84
  72. Chen EY, Liao YC, Smith DH, et al. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics. 1989;4:479–497
  73. Goossens M, Brauner R, Czernichow P, et al. Isolated growth hormone (GH) deficiency type 1A associated with a double deletion in the human GH gene cluster. The Journal of Clinical Endocrinology and Metabolism. 1986;62:712–716
  74. Akinci A, Kanaka C, Eble A, et al. Isolated growth hormone (GH) deficiency type IA associated with a 45-kilobase gene deletion within the human GH gene cluster. The Journal of Clinical Endocrinology and Metabolism. 1992;75:437–441
  75. Parks JS, Nielsen PV, Sexton LA, et al. An effect of gene dosage on production of human chorionic somatomammotropin. The Journal of Clinical Endocrinology and Metabolism. 1985;60(5):994–997
  76. Simon P, Decoster C, Brocas H, et al. Absence of human chorionic somatomammotropin during pregnancy associated with two types of gene deletion. Human Genetics. 1986;74:235–238
  77. Fall CH, Pandit AN, Law CM, et al. Size at birth and plasma insulin-like growth factor-1 concentrations. Archives of Disease in Childhood. 1995;73:287–293
  78. Green LR, Kawagoe Y, Hill DJ, et al. The effect of intermittent umbilical cord occlusion on insulin-like growth factors and their binding proteins in preterm and near-term ovine fetuses. Journal of Endocrinology. 2000;166:565–577
  79. Jaquet D, Leger J, Levy-Marchal C, et al. Ontogeny of leptin in human fetuses and newborns: effect of intrauterine growth retardation on serum leptin concentrations. The Journal of Clinical Endocrinology and Metabolism. 1998;83:1243–1246
  80. Yang SW, Yu JS. Relationship of insulin-like growth factor-I, insulin-like growth factor binding protein-3, insulin, growth hormone in cord blood and maternal factors with birth height and birthweight. Pediatric International. 2000;42:31–36
  81. Ozkan H, Aydin A, Demir N, et al. Associations of IGF-I, IGFBP-1 and IGFBP-3 on intrauterine growth and early catch-up growth. Biology of the Neonate. 1999;76:274–282
  82. Albertsson-Wikland K, Boguszewski M, Karlberg J. Children born small-for-gestational age: postnatal growth and hormonal status. Hormone Research. 1998;49(Suppl 2):7–13
  83. Barker DJ. Intrauterine programming of adult diseases. Molecular Medicine Today. 1995;1:418–423
  84. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595–601
  85. Hales CN, Barker DJ. The thrifty phenotype hypothesis. British Medical Bulletin. 2001;60:5–20
  86. Bloomfield FH, Oliver MH, Harding JE. The late effects of fetal growth patterns. Archives of Disease in Childhood Fetal and Neonatal Edition. 2006;91:F299–F304
  87. Plagemann A. Perinatal nutrition and hormone-dependent programming of food intake. Hormone Research. 2006;65(Suppl 3):83–89
  88. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genetics. 1997;15:106–110
  89. Elsas LJ, Endo F, Strumlauf E, et al. Leprechaunism: an inherited defect in a high-affinity insulin receptor. American Journal of Human Genetics. 1985;37:73–88
  90. Randle PJ. Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:269–275
  91. Velho G, Petersen KF, Perseghin G, et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. The Journal of Clinical Investigation. 1996;98:1755–1761
  92. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia. 1999;42:1033–1049
  93. Eriksson JG, Lindi V, Uusitupa M, et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth. Diabetes. 2002;51:2321–2324
  94. Gesina E, Blondeau B, Milet A, et al. Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia. 2006;49:2939–2947
  95. Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development. Hormone Research. 2006;65(Suppl 3):98–104
  96. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. The New England Journal of Medicine. 1976;295:349–353
  97. Plagemann A, Harder T, Rake A, et al. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome x-like alterations in adulthood of neonatally overfed rats. Brain Research. 1999;836:146–155
  98. Plagemann A, Harder T, Rake A, et al. Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rats. Journal of Neuroendocrinology. 1999;11:541–546
  99. Dulloo AG, Jacquet J, Seydoux J, et al. The thrifty ‘catch-up fat’ phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome. International Journal of Obesity. 2006;30(Suppl 4):S23–S35
  100. Dulloo AG. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. Hormone Research. 2006;65(Suppl 3):90–97
  101. Dulloo AG, Jacquet J, Montani JP. Pathways from weight fluctuations to metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. International Journal of Obesity and Related Metabolic Disorders. 2002;26(Suppl 2):S46–S57
  102. Hofman PL, Cutfield WS, Robinson EM, et al. Insulin resistance in short children with intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism. 1997;82:402–406
  103. Jornayvaz FR, Selz R, Tappy L, et al. Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation. Metabolism. 2004;53:847–851
  104. Cettour-Rose P, Samec S, Russell AP, et al. Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes. 2005;54:751–756
  105. Dulloo AG. A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome. Acta Physiologica Scandinavica. 2005;184:295–307
  106. Crescenzo R, Samec S, Antic V, et al. A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes. 2003;52:1090–1097
  107. Barker DJ. In utero programming of chronic disease. Clinical Science. 1998;95:115–128
  108. van Weissenbruch MM, Delemarre-van de Waal HA. Early influences on the tempo of puberty. Hormone Research. 2006;65(Suppl 3):105–111
  109. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nature Neuroscience. 2004;7:847–854
  110. Vickers MH, Gluckman PD, Coveny AH, et al. Neonatal leptin treatment reverses developmental programming. Endocrinology. 2005;146:4211–4216
  111. Yura S, Itoh H, Sagawa N, et al. Role of premature leptin surge in obesity resulting from intrauterine under-nutrition. Cell Metabolism. 2005;1:371–378
  112. Farooqi IS, O'Rahilly S. New advances in the genetics of early onset obesity. International Journal of Obesity. 2005;29:1149–1152
  113. Tanner JM. Growth from birth to two: a critical review. Acta Medica Auxologica. 1994;26:7–45
  114. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatric Research. 1995;38:733–739
  115. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatrica Scandinavica. 1994;399(Suppl):64–70
  116. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, et al. Children born small for gestational age: do they catch up?. Pediatric Research. 1995;38:267–271
  117. Albertsson-Wikland K, Wennergren G, Wennergren M, et al. Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatrica. 1993;82:438–443
  118. Luo ZC, Albertsson-Wikland K, Karlberg J. Length and body mass index at birth and target height influences on patterns of postnatal growth in children born small for gestational age. Pediatrics. 1998;102:E72
  119. Ibanez L, Ferrer A, Marcos MV, et al. Early puberty: rapid progression and reduced final height in girls with low birth weight. Pediatrics. 2000;106(5):E72
  120. Cook CJ, Gluckman PD, Williams C, et al. Precocial neural function in the growth-retarded fetal lamb. Pediatric Research. 1988;24:600–604
  121. Ibanez L, de Zegher F. Puberty and prenatal growth. Molecular and Cellular Endocrinology. 2006;254–255:22–25
  122. Ibanez L, de Zegher F. Puberty after prenatal growth restraint. Hormone Research. 2006;65(Suppl 3):112–115
  123. Ducharme JR, Grumbach MM. Studies on the effects of human growth hormone in premature infants. The Journal of Clinical Investigation. 1961;40:243–247
  124. van Toledo-Eppinga L. Growth promoting interventions in preterm infants. PhD Thesis. Amsterdam: Free University Amsterdam; 1995.
  125. de Zegher F, Ong KK, Ibanez L, et al. Growth hormone therapy in short children born small for gestational age. Hormone Research. 2006;65(Suppl 3):145–152
  126. Cutfield WS, Lindberg A, Rapaport R, et al. Safety of growth hormone treatment in children born small for gestational age: the US trial and KIGS analysis. Hormone Research. 2006;65(Suppl 3):153–159

PII: S1521-690X(07)00063-2

doi: 10.1016/j.beem.2007.07.010

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 173-190 , February 2008

Article Tools